Australian Institute of Health and Welfare (2021) Alcohol and other drug treatment services in Australia annual report, AIHW, Australian Government, accessed 29 May 2022.
Australian Institute of Health and Welfare. (2021). Alcohol and other drug treatment services in Australia annual report. Retrieved from https://pp.aihw.gov.au/reports/alcohol-other-drug-treatment-services/alcohol-other-drug-treatment-services-australia
Alcohol and other drug treatment services in Australia annual report. Australian Institute of Health and Welfare, 16 July 2021, https://pp.aihw.gov.au/reports/alcohol-other-drug-treatment-services/alcohol-other-drug-treatment-services-australia
Australian Institute of Health and Welfare. Alcohol and other drug treatment services in Australia annual report [Internet]. Canberra: Australian Institute of Health and Welfare, 2021 [cited 2022 May. 29]. Available from: https://pp.aihw.gov.au/reports/alcohol-other-drug-treatment-services/alcohol-other-drug-treatment-services-australia
Australian Institute of Health and Welfare (AIHW) 2021, Alcohol and other drug treatment services in Australia annual report, viewed 29 May 2022, https://pp.aihw.gov.au/reports/alcohol-other-drug-treatment-services/alcohol-other-drug-treatment-services-australia
Get citations as an Endnote file:
On this page:
In 2019–20, 85 publicly funded alcohol and other drug treatment agencies in South Australia provided 9,690 closed treatment episodes to 7,131 clients (tables SA.1, SCR.21). South Australia reported:
The visualisation shows that 9,690 closed treatment episodes were provided to an estimated 7,131 clients in South Australia in 2019–20. This equates to a rate of 624 episodes and 459 clients per 100,000 population, a lower rate than the 1,064 episodes and 624 clients per 100,000 population reported nationally.
In 2019–20, most (88%) clients in South Australia attended 1 agency, and received an average of 1.4 closed treatment episodes, which is lower than the national average of 1.7 treatment episodes (tables SCR.21, SCR.23).
The visualisation includes a series of horizontal bar graphs showing that, in 2019–20, nearly all (99%) clients in South Australia received treatment for their own drug use. Of these clients, almost two-thirds (65%) were male, 54% were aged 20–39, and 13% were Indigenous Australians. Nearly all clients (98%) listed English as their preferred language and most (91%) were born in Australia.
Over the period 2015–16 to 2019–20, 29,937 clients received treatment in South Australia. Of these clients:
In 2019–20, for clients in South Australia receiving treatment episodes for their own alcohol or drug use:
Clients can nominate up to 5 additional drugs of concern; these drugs are not necessarily the subject of any treatment within the episode (see Technical notes).
In 2019–20, when the client reported additional drugs of concern:
Over the period 2015–16 to 2019–20:
The proportion of treatment episodes for amphetamines as a principal drug of concern has been consistently higher in South Australia than the national proportion. This is related to a state Government legislated program regarding assessments provided under a Police Drug Diversion initiative. The program results in comparatively high proportions of engagement with methamphetamine users. In addition, due to the Cannabis Expiation Notice legislation in South Australia, adult simple cannabis offences are not diverted to treatment and so are not included in the data (see the Data Quality Statement).
The grouped horizontal bar chart shows that, in 2019–20, amphetamines was the most common principal drug of concern in treatment episodes provided to clients in South Australia for their own drug use (35%). This was followed by alcohol (32%), cannabis (15%), and nicotine (6.9%). Nicotine was the most common additional drug of concern (27%), followed by cannabis (22%), and alcohol and amphetamines (both 12%).
The line graph shows that methamphetamine is the most common drug of concern among meth/amphetamine-related treatment episodes for clients’ own drug use. The proportion of methamphetamine-related episodes increased from 50% in 2015–16 to 79% in 2019–20. Conversely, there was a decrease in the proportion of episodes relating to amphetamines not further defined (from 36% to 11%).
The stacked horizontal bar chart shows the method of use for treatment episodes related to clients’ own use of meth/amphetamines in South Australia in 2019–20. Smoking was the most common method of use for all treatment episodes (ranging from 45% to 65%). Injecting was the second most common method of use for all treatment episodes (ranging from 30% to 40%).
In 2019–20, for treatment episodes in South Australia:
South Australia reported a high proportion of treatment episodes where assessment only is the most common treatment type, relating in part to the SA Police Drug Diversion Initiative (PDDI).
The grouped horizontal bar chart shows that, in 2019–20, the most common main treatment type provided to clients in South Australia for their own drug use was assessment only (32% of episodes). This was followed by counselling (29%), withdrawal management (16%), and support and case management (7.7%). The most common additional treatment type was support and case management (14% of episodes).
In 2019–20, in South Australia:
Over the 5 years to 2019–20, the number of publicly funded treatment agencies in South Australia increased from 78 to 85 (Table SA.1).
The horizontal bar chart shows that most treatment agencies in South Australia were located in Major cities (39 agencies), followed by Outer regional (20 agencies) and Inner regional (19 agencies) areas. Of the total 85 treatment agencies, most (55 agencies) were non-government agencies.
We'd love to know any feedback that you have about the AIHW website, its contents or reports.
The browser you are using to browse this website is outdated and some features may not display properly or be accessible to you. Please use a more recent browser for the best user experience.